Literature DB >> 7287681

Papain inhibitions by optically active E-64 analogs.

M Tamai, K Hanada, T Adachi, K Oguma, K Kashiwagi, S Omura, M Ohzeki.   

Abstract

Modification of E-64 focused on the terminal agmatine for practical use led to some potent analogs which were successfully obtained by a stereoselective synthesis using D-tartaric acid as a starting material. Ep-475 (id. E-64-c), in which the agmatine was replaced by 3-methyl-butylamine, was found to react with the essential SH of papain in accord with the decrease of activity. [3H]Ep-475 was irreversibly incorporated into papain in an equimolar ratio. None of the analogs showed any effect on thiol enzymes other than proteolytic ones.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7287681     DOI: 10.1093/oxfordjournals.jbchem.a133458

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  17 in total

1.  Degradation of myelin basic protein by calcium-activated neutral protease (CANP) in human brain and inhibition by E-64 analogue.

Authors:  K Yanagisawa; S Sato; N Amaya; T Miyatake
Journal:  Neurochem Res       Date:  1983-10       Impact factor: 3.996

2.  Biosynthesis and secretion of procollagenase by rabbit synovial fibroblasts. Inhibition of procollagenase secretion by monensin and evidence for glycosylation of procollagenase.

Authors:  H Nagase; C E Brinckerhoff; C A Vater; E D Harris
Journal:  Biochem J       Date:  1983-08-15       Impact factor: 3.857

3.  The cytoskeleton of microvilli of leech photoreceptors. A stable bundle of actin microfilaments.

Authors:  A D Blest; H G De Couet; C Sigmund
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

4.  Actin in cellular components of the basement membrane of the compound eye of a blowfly.

Authors:  A D Blest; H G De Couet
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

5.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.

Authors:  A J Barrett; A A Kembhavi; M A Brown; H Kirschke; C G Knight; M Tamai; K Hanada
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

6.  The purification and properties of cathepsin L from rabbit liver.

Authors:  R W Mason; M A Taylor; D J Etherington
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

7.  Antiviral effects of a thiol protease inhibitor on foot-and-mouth disease virus.

Authors:  L G Kleina; M J Grubman
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  Thiol protease-specific inhibitor E-64 arrests human epidermoid carcinoma A431 cells at mitotic metaphase.

Authors:  Y Shoji-Kasai; M Senshu; S Iwashita; K Imahori
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

9.  Conversion of myelin-associated glycoprotein (MAG) to a smaller derivative by calcium activated neutral protease (CANP)-like enzyme in myelin and inhibition by E-64 analogue.

Authors:  S Sato; K Yanagisawa; T Miyatake
Journal:  Neurochem Res       Date:  1984-05       Impact factor: 3.996

Review 10.  Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders.

Authors:  Vivian Hook; Michael Yoon; Charles Mosier; Gen Ito; Sonia Podvin; Brian P Head; Robert Rissman; Anthony J O'Donoghue; Gregory Hook
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-04-17       Impact factor: 3.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.